{"result": "(\"entity\"<|>MICRONUTRIENTS<|>EVENT<|>Micronutrients such as Fe, Ca, and vitamins are essential for the recovery of patients with Celiac Disease and are often supplemented in their diets.)\n##\n(\"entity\"<|>GLUTEN-FREE DIET<|>EVENT<|>The gluten-free diet is a dietary regimen that excludes gluten, which is crucial for managing Celiac Disease and preventing its complications.)\n##\n(\"entity\"<|>CICLITIRA PJ<|>PERSON<|>P.J. Ciclitira is a researcher who has contributed to the technical review on Celiac Sprue published by the American Gastroenterological Association.)\n##\n(\"entity\"<|>BOOTH CC<|>PERSON<|>C.C. Booth is a researcher known for his historical analysis of Celiac Disease.)\n##\n(\"entity\"<|>FERGUSON A<|>PERSON<|>A. Ferguson is a researcher who has studied the clinical and pathological spectrum of Celiac Disease.)\n##\n(\"entity\"<|>NIWINSKI M<|>PERSON<|>M. Niwinski is a researcher who has published on advances in Celiac Disease and gluten-free diets.)\n##\n(\"entity\"<|>SCOTT EM<|>PERSON<|>E.M. Scott is a researcher who has provided guidelines for osteoporosis in Celiac Disease.)\n##\n(\"relationship\"<|>MICRONUTRIENTS<|>GLUTEN-FREE DIET<|>Micronutrients are often supplemented in the gluten-free diet to aid recovery in Celiac Disease patients<|>7)\n##\n(\"relationship\"<|>CICLITIRA PJ<|>AGA INSTITUTE<|>P.J. Ciclitira's work is associated with the AGA Institute's technical review on Celiac Sprue<|>8)\n##\n(\"relationship\"<|>BOOTH CC<|>GASTROENTEROLOGY<|>C.C. Booth's historical analysis contributes to the understanding of Celiac Disease in gastroenterology<|>7)\n##\n(\"relationship\"<|>FERGUSON A<|>GASTROENTEROLOGY<|>A. Ferguson's research on the spectrum of Celiac Disease is relevant to gastroenterology<|>7)\n##\n(\"relationship\"<|>NIWINSKI M<|>GASTROENTEROLOGY<|>M. Niwinski's work on advances in Celiac Disease is significant for gastroenterology<|>7)\n##\n(\"relationship\"<|>SCOTT EM<|>GASTROENTEROLOGY<|>E.M. Scott's guidelines for osteoporosis in Celiac Disease are important for gastroenterological practice<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: position statement: Celiac Sprue. Gastroenterology\n                                                                 2001; 120: 1522-5.\n7.    Soporte nutricional artificial                         3.  Ciclitira PJ, King AL, Fraser JS. AGA technical review\n                                                                 on Celiac Sprue. American Gastroenterological As-\n    Los pacientes celiacos pueden presentar una intole-          sociation. Gastroenterology 2001; 120: 1526-40.\nrancia secundaria a la lactosa, principalmente al diag-      4.  Booth,CC. history of celiac disease. BMJ 1989; 298-\nnóstico de la enfermedad, que suele desaparecer a                527.\nmedida que la mucosa intestinal se recupera. Por tan-        5.  Pallav K, Kabbani T, Tariq S, Vanga R, Kelly CP, Le-\nto, inicialmente es necesario realizar una restricción           ffler DA. Clinical utility of celiac disease-associated\ntemporal de la lactosa de la dieta. También suele ser            HLA testing. Dig Dis Sci. 2014 Sep;59(9):2199-206.\nnecesario al inicio restringir la grasa y suplementar cier-  6.  Woodward J. Improving outcomes of refractory\ntos micronutrientes (Fe, Ca, ácido fólico y las vitaminas        celiac disease - current and emerging treatment\nliposolubles). Con este fin, pueden utilizarse temporal-         strategies     Clin    Exp     Gastroenterol.       2016    Aug\nmente suplementos nutricionales adaptados a las ne-              3;9:225-36.\n---\n                                                                   Tema 17.    Enfermedad celiaca. Dieta controlada en gluten            303\n\n\n\n  7.  Shan, L, Molberg, O, Parrot, I, et al. Structural ba-                  17.  Kagnoff, MF.AGA Institute Medical Position State-\n      sis for gluten intolerance in celiac sprue. Science                         ment on the Diagnosis and management of Celiac\n      2002; 297:2275.                                                             Disease . Gastroenterology. 2006 Dec;131(6):1977-\n  8.  Fasano A, Sapone A, Zevallos V, Schuppan D.                                 80.\n      Nonceliac      gluten     sensitivity.    Gastroenterology.            18.  National Institutes of Health Consensus Develop-\n      2015 May;148(6):1195-204.                                                   ment Conference Statement. Celiac Disease 2004.\n  9.  Ferguson, A, Arranz, E, O’Mahoney, S. Clinical and                          Gastroenterology. 2005 Apr;128(4 Suppl 1):S1-9.\n      pathological spectrum of coeliac disease-active,                            Disponible en http://consensus.nih.gov\n      silent, latent, potential. Gut 1993; 34:150.                           19.  Askling, J, Linet, M, Gridley, G, et al. Cancer inci-\n10.   Goddard CJ, Gillett HR. Complications of coeliac                            dence in a population-based cohort of individuals\n      disease: are all patients at risk? Postgrad Med J.                          hospitalized with celiac disease or dermatitis her-\n      2006 Nov;82(973):705-12.                                                    petiformis. Gastroenterology 2002; 123:1428.\n11.   McKinley, M, Leibowitz, S, Bronzo, R, et al. Appro-                    20.  Niewinski,M. Advances in Celiac Disease and Glu-\n      priate response to pneumococcal vaccine in celiac                           ten-Free Diet. J Am Diet Assoc. 2008;108:661-\n      sprue. J Clin Gastroenterol 1995; 20:113.                                   672.\n12.   Han Y, Chen W, Li P, Ye J. Association Between                         21.  Pietzak MM. Follow-up of patients with celiac di-\n      Coeliac Disease and Risk of Any Malignancy and                              sease: Achieving compliance with treatment. Gas-\n      Gastrointestinal       Malignancy:       A    Meta-Analysis.                troenterology. 2005;128(suppl 1): S135-S141.\n      Medicine (Baltimore). 2015 Sep;94(38):e1612.                           22.  Scott, EM, Gaywood, I, Scott, BB. Guidelines for\n13.   Cosnes, J, Cellier, C, Viola, S,        et al. Incidence of                 osteoporosis in coeliac disease and inflammatory\n      autoimmune diseases in celiac disease: protective                           bowel disease. British Society of Gastroenterology.\n      effect of the gluten-free diet. Clin Gastroenterol                          Gut 2000; 46 Suppl 1:11.\n      Hepatol 2008; 6:753.                                                   23.  The Gluten-Free Certification Organization. http://\n14.   Marciano F, Savoia M, Vajro P. Celiac disease-rela-                         www.gfco.org. Accessed December 22, 2008.\n      ted hepatic injury: Insights into associated condi-                    24.  Lee, SK, Lo, W, Meme\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>CELIAC SPRUE<|>EVENT<|>Celiac Sprue is an autoimmune disorder that affects the digestive system, particularly the small intestine, in response to gluten consumption.)\n##\n(\"entity\"<|>GASTROENTEROLOGY<|>ORGANIZATION<|>Gastroenterology is a branch of medicine focused on the digestive system and its disorders, including conditions like Celiac Sprue.)\n##\n(\"entity\"<|>NATIONAL INSTITUTES OF HEALTH<|>ORGANIZATION<|>The National Institutes of Health is a part of the U.S. Department of Health and Human Services and is responsible for biomedical and public health research, including studies on Celiac Disease.)\n##\n(\"entity\"<|>AGA INSTITUTE<|>ORGANIZATION<|>The AGA Institute is a professional organization dedicated to advancing the science and practice of gastroenterology, including the management of Celiac Disease.)\n##\n(\"entity\"<|>FASANO A<|>PERSON<|>Alessio Fasano is a prominent researcher in the field of Celiac Disease and gluten sensitivity, contributing significantly to the understanding and management of these conditions.)\n##\n(\"entity\"<|>SHAN L<|>PERSON<|>L. Shan is a researcher who has contributed to the structural analysis of gluten intolerance in Celiac Sprue.)\n##\n(\"entity\"<|>KAGNOFF MF<|>PERSON<|>M.F. Kagnoff is a medical professional associated with the AGA Institute, known for his work on the diagnosis and management of Celiac Disease.)\n##\n(\"entity\"<|>PALLAV K<|>PERSON<|>K. Pallav is a researcher who has studied the clinical utility of HLA testing in relation to Celiac Disease.)\n##\n(\"entity\"<|>GODDARD CJ<|>PERSON<|>C.J. Goddard is a researcher who has investigated the complications associated with Celiac Disease.)\n##\n(\"entity\"<|>COSNES J<|>PERSON<|>J. Cosnes is a researcher who has studied the incidence of autoimmune diseases in patients with Celiac Disease.)\n##\n(\"relationship\"<|>FASANO A<|>AGA INSTITUTE<|>Alessio Fasano is associated with the AGA Institute and has contributed to the understanding of Celiac Disease<|>8)\n##\n(\"relationship\"<|>KAGNOFF MF<|>AGA INSTITUTE<|>M.F. Kagnoff is affiliated with the AGA Institute and has worked on Celiac Disease management<|>8)\n##\n(\"relationship\"<|>SHAN L<|>GASTROENTEROLOGY<|>L. Shan's research on gluten intolerance is relevant to the field of gastroenterology<|>7)\n##\n(\"relationship\"<|>PALLAV K<|>GASTROENTEROLOGY<|>K. Pallav's studies on HLA testing are significant for gastroenterological conditions like Celiac Disease<|>7)\n##\n(\"relationship\"<|>GODDARD CJ<|>GASTROENTEROLOGY<|>C.J. Goddard's research on complications of Celiac Disease is pertinent to gastroenterology<|>7)\n##\n(\"relationship\"<|>COSNES J<|>GASTROENTEROLOGY<|>J. Cosnes' work on autoimmune diseases in Celiac Disease is relevant to gastroenterology<|>7)\n##\n(\"relationship\"<|>NATIONAL INSTITUTES OF HEALTH<|>AGA INSTITUTE<|>The National Institutes of Health collaborates with the AGA Institute on research related to Celiac Disease<|>6)\n<|COMPLETE|>"}]}